Pulmonary dysfunction in pediatric oncology patients

Pediatric Hematology and Oncology

Volumn 21, Issue 2, 2004, Pages 175-195

  Meyer, Sascha ^a   Reinhard, Harald ^a   Gottschling, Sven ^a   Nunold, Holger ^a   Graf, Norbert ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Differential diagnosis; Dyspnea; Pediatric oncology; Pulmonary dysfunction

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTHRACYCLINE DERIVATIVE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; ASPARAGINASE; BLEOMYCIN; BUSULFAN; CARBOPLATIN; CARMUSTINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; ITRACONAZOLE; LOMUSTINE; MELPHALAN; METHOTREXATE; NITROSOUREA DERIVATIVE; RITUXIMAB; SEMUSTINE; TENIPOSIDE; VINBLASTINE; VINCRISTINE; VINDESINE; VORICONAZOLE;

AIRWAY OBSTRUCTION; ANGIONEUROTIC EDEMA; BACTERIAL PNEUMONIA; BONE MARROW TRANSPLANTATION; BRONCHOSPASM; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; CHILDHOOD CANCER; CONGESTIVE CARDIOMYOPATHY; COUGHING; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIFFUSE ALVEOLAR DAMAGE; DYSPNEA; EOSINOPHILIA; FEVER; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART TAMPONADE; HEMORRHAGIC MYOPERICARDITIS; HUMAN; HYPERLEUKOCYTOSIS SYNDROME; HYPERSENSITIVITY REACTION; INFECTION; INTERSTITIAL PNEUMONIA; KIDNEY DYSFUNCTION; LEUKOCYTOSIS; LUNG ALVEOLUS CELL; LUNG DISEASE; LUNG EDEMA; LUNG FIBROSIS; LUNG INFECTION; LUNG INFILTRATE; LUNG INJURY; LUNG TOXICITY; MEDICAL LITERATURE; MUCOSA INFLAMMATION; MYCOSIS; PERICARDIAL EFFUSION; PERICARDITIS; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE COMPLICATION; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; RETINOIC ACID SYNDROME; REVIEW; RISK FACTOR; SUPERIOR CAVA VEIN SYNDROME; SYNDROME; TACHYPNEA; URTICARIA; VIRUS INFECTION;

ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; CHILD; DYSPNEA; HUMANS; IATROGENIC DISEASE; INFECTION; LUNG DISEASES; NEOPLASMS;

EID: 1542289796     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010490272894     Document Type: Review

References (95)

1. Kelly KM, Lange B. Oncologic emergencies. Pediatr Clin North Am. 1997;44:809-830.
2. Lange B, D'Angio G, Ross AJ, O'Neill JA, Packer RJ. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology, ed 2. Philadelphia: JB Lippincott; 1992;315-334.
3. Hancock BJ, Di Lorenzo M, Yousef S, Yazbeck S, Marcotte JE, Collin PP. Childhood primary pulmonary neoplasms. J Pediatr Surg. 1993;28:1133-1136.
4. Ishii E, Yamada S, Kano S, et al. Pulmonary and pleural involvements at initial diagnosis in children with malignant neoplasms. Am J Pediatr Hematolol Oncol. 1989;11:281-285.
5. Wischniewski E, Klaeber HG, Oppermann J, Guntschera J, Eichhorn T, Erler T. Neonatal respiratory distress due to a nasal glioma. Klin Paediatr. 2001;213:139-141.
6. Heath JA. Leukaemia presenting as respiratory distress in a child with asthma. J Paediatr Child Health. 2001;7:397-399.
7. Linden V, Karlen J, Olsson M, et al. Successful extracorporeal membrane oxygenation in four children with malignant disease and severe Pneumocystis carinii pneumonia. Med Pediatr Oncol. 1999;32:25-31.
8. Tallman MS, Andersen JW, Schiffer CA, et al. Clincal description of 44 patients with acute promyeloctic leukemia who developed the retinoic acid syndrome. Blood. 2000;95:90-95.
9. Aisenberg AC. Problems in Hodgkin's disease management. Blood. 1999;93:761-779.
10. Fulgoni P, Zoia MC, Corsico A, et al. Lung function in survivors of childhood acute lymphoblastic leukaemia. Chest. 1999;116:1163-1167.
11. Cerveri I, Fulgoni P, Giorgiani G, et al. Lung function abnormalities after bone marrow transplantation in children: has the trend recently changed? Chest. 2001;120:1900-1906.
12. Griese M, Rampf U, Hofmann D, Fuehrer M, Reinhardt D, Bender-Goetze C. Pulmonary complications after bone marrow transplantation in children: twenty-four years of experience in a single pediatric center. Pediatr Pulmonol. 2000;30:393-401.
13. Leneveu H, Bremont F, Rubie H, et al. Respiratory function in children undergoing bone marrow transplantation. Pediatr Pulmonol. 1999;28:31-38.
14. Neve V, Foot ABM, Michon J, Fourquet A, Zucker JM, Boule M. Longitudinal clinical and functional pulmonary follow-up after megatherapy, fractionated total body irradiation, and autologous bone marrow transplantation for metastatic neuroblastoma. Med Ped Oncol. 1999;32:170-176.
15. Bilgrami SF, Metersky ML, McNally D, et al. Idiopathic pneumonia syndrome following myeloablative chemotherapy and autologous transplantation. Ann Pharmacother. 2001;35:196-201.
16. Suzuki T, Ebina M, Yaekashiwa M, et al. Bilateral pneumothoraces with multiple bullae in a patient with asymptomatic bronchiolitis obliterans 10 years after bone marrow transplantation. Bone Marrow Transplant. 1999;23:829-831.
17. Crom DB, Chathaway DK, Tolley EA, Mulhern RK, Hudson MM. Health status and health-related quality of life in long-term adult survivors of pediatric solid tumors. Int J Cancer Suppl. 1999;12:25-31.
18. Toren A, Nagler A. Massive pericardial effusion complicating the course of chronic graft-versus-host disease (cGVHD) in a child with acute lymphoblastic leukaemia following allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997;20:805-807.
19. Woodward JP, Gulbahce E, Shreve M, et al. Pulmonary cytolytic thrombi: a newly recognized complication of stem cell transplantation. Bone Marrow Transplant. 2000;25:293-300.
20. Meyer S, Aliani S, Graf N, Reinhard H, Gottschling S. Sedation with midazolam and ketamine for invasive procedures in children with malignancies and hematological disorders: a prospective study with reference to the sympathomimetic properties of ketamine. Pediatr Hematol Oncol. 2003;20:291-301.
21. Meyer S, Reinhard H, Ziegler K, et al. Ganglioneuroma: radiological and metabolic features in 4 children. Pediatr Hematol Oncol. 2002;19:501-508.
22. King DR, Patrick LE, Ginn-Pease ME, McCoy KS, Klopfenstein K. Pulmonary function is compromised in children with mediastinal lymphoma. J Pediatr Surg. 1997;3:294-299.
23. Wolffe J, Grier HE, Klar N, et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med. 2000;342:326-333.
24. Manning HL, Leiter JC. Respiratory control and respiratory sensation in a patient with a ganglioglioma within the dorsocaudal brain stem. Am J Respir Crit Care Med. 2000;161:2100-2106.
25. Parisi MT, Fahmy JL, Kaminsky CK, Malogolowkin MH. Complications of cancer therapy in children: a radiologist's guide. Radiographics. 1999;19:283-297.
26. Yellin A, Mandel M, Rechavi G, Neuman Y, Ramot B, Lieberman Y. Superior vena cava syndrome associated with lymphoma. Am J Dis Child. 1992;146:1060-1063.
27. Takatsuka H, Wakae T, Mori A, et al. Superior vena cava syndrome after bone marrow transplantation caused by aspergillosis: a case report. Hematology. 2002;7:169-172.
28. Dilworth KE, McHugh K, Stacey S, Howard RF. Mediastinal mass obscured by a large pericardial effusion in a child: a potential cause of serious anaesthetic morbidity. Paediatr Anaesth. 2001;11:479-482.
29. Kuga T, Inoue T, Taniguchi S, Zempo N, Esato K. Management of respiratory distress in children and adolescents with cancer. Med Pediatr Oncol. 1999;33:577-579.
30. Cuttner J, Holland JF, Norton L, Ambinder E, Button G, Meyer RJ. Therapeutic leukapheresis for hyperleukocytosis in acute myelocytic leukaemia. Med Pediatr Oncol. 1983;11:76-78.
31. Kamen BA, Summers CP, Pearson HA. Exchange transfusion as a treatment for hyperleukocytosis, anemia, and metabolic abnormalities in a patient with leukaemia. J Pediatr. 1980;96:1045-1046.
32. Cohen MC, Kaschula RO. Primary pulmonary tumors in childhood: a review of 31 years' experience and the literature. Pediatr Pulmonol. 1992;14:222-232.
33. Abbasi S, Shenep JL, Hughes WT, Flynn PM. Aspergillosis in children with cancer: a 34-year experience. Clin Infect Dis. 1999;29:1210-1219.
34. Shenep JL, Flynn PM. Pulmonary fungal infections in immunocompromised children. Curr Opin Pediatr. 1997;9:213-218.
35. Chen CC, Huang LM, Chang YL, King CC, Lin KH. Acute respiratory distress syndrome due to tuberculosis in a child after allogenic bone marrow transplantation for acute lymphoblastic leukaemia. J Formos Med Assoc. 1999;98:701-704.
36. Gonzalez Y, Martino R, Badell I. Pulmonary enterovirus infections in stem cell recipients. Bone Marrow Transplant. 1999;23:511-513.
37. Ljungman P. Cytomegalovirus pneumonia: presentation, diagnosis, and treatment. Semin Respir Infect. 1995;10:209-215.
38. Oh YW, Effmann EL, Godwin JD. Pulmonary infections in immunocompromised hosts: the importance of correlating the conventional radiologic appearance with the clinical setting. Radiology. 2000;217:647-656.
39. Schmitt HJ, Kontny U. Infektionskrankheiten bei immmunsupprimierten Kindern. In: Krebs bei Kindern und Jugendlichen. Klinik und Praxis der Pädiatrischen Onkologie. 4. und überarbeitete Auflage. Herausgeber: Gutjahr P; Deutscher Ärzteverlag Koeln: 1999;S.205-S.237.
40. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis. 2001;32:358-366.
41. Korones DN, Hussong MR, Gullace MA. Routine chest radiograühy of children with cancer hospitalised for fever and neutropenia: is it really necessary? Cancer. 1997;80:1160-1164.
42. Heussel CP, Kauczor HU, Heussel GE, et al. Pneumonia in febrile neutropenic patients and in bone marrow and blood-stem cell recipients: use of high resolution computed tomography. J Clin Oncol. 1999;17:796-805.
43. Erler T, Schmidt K, Klaeber HG, Wischnieski, Holfeld R. Successful surfactant therapy of ARDS in an immunodepressed child. Klin Padiatr. 2001;214:109-112.
44. Keengwe IN, Stansfield F, Eden OB, Nelhans ND, Dearlove OR, Sharples A. Paediatric oncology and intensive care treatments: changing trends. Arch Dis Child. 1999;80:553-555.
45. Sivan Y, Schwartz PH, Shonfeld T, Cohen IJ, Newth CJ. Outcome of oncology patients in the pediatric intensive care unit. Intensive Care Med. 1991;17:11-15.
46. Ben-Abraham R, Weinbroum AA, Augerten A, et al. Acute respiratory distress syndrome in children with malignancies - can we predict outcome? J Crit Care. 2001;16:54-58.
47. Heying R, Schneider DT, Korholz D, Stannigel H, Lemburg P, Gobel U. Efficacy and outcome of intensive care in pediatric oncologic patients. Crit Care Med. 2001;29:2276-2280.
48. Hudson MM, Weinsten HJ, Donaldson SS, et al. Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease. J Clin Oncol. 1992;11:1080-1084.
49. Erasmaus JJ, McAdams HP, Rossi SE. Drug-induced lung-injury. Semin Roentgenol. 2001;37:72-81.
50. Jenney MEM, Faragher EB, PH Morris Jones, Woodcock A. Lung function and exercise capacity in survivors of childhood leukaemia. Med Pediatr Oncol. 1995;24:222-230.
51. Miller RM, Fusner JE, Fink RJ, et al. Pulmonary function abnormalities in long-term survivors of childhood cancer. Med Pediatr Oncol. 1986;14:202-207.
52. Nysom K, Olsen JH, Hertz H, Hesse B. Pulmonary function after treatment for acute lymphoblastic leukaemia in childhood. Br J Cancer. 1998;78:21-27.
53. Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics. 2000;20:1245-1259.
54. Hirsch A, Vander Els N, Straus DJ, et al. Effect of ABVD chemotherapy with and without mantle or mediastinal irradition on pulmonary function and symptoms in early-stage Hodgkin's disease. J Clin Oncol. 1996;14:1297-1305.
55. Kharasch VS, Lipsitz S, Santis W, Hallolwell JA, Goorin A. Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors. Med Pediatr Oncol. 1996;27:85-91.
56. Abid AH, Malhotra V, Perry MC. Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol. 2001;13:242-248.
57. McKibben A, Hinson J. Chemotherapy associated pulmonary injury. In: Perry MC, ed. The Chemotherapy Source Book, ed 3. Philadelphia: Lippincott Williams & Wilkins; 2001.
58. Cooper AD, White DA, Matthay RA. Drug-induced pulmonary disease. Am Rev Respir Dis. 1986;133:321-340.
59. Taetle R, Dickman PS, Feldman PS. Pulmonary histological changes associated with melphalan therapy. Cancer. 1978;42:1239-1245.
60. Goucher G, Rowland V, HawkinsJ. Melphalan-induced pulmonary interstitial fibrosis. Chest. 1980;77:805-806.
61. Malik SW, Myers JL, DeRemee RA, Specks U. Lung toxicity associated with cyclophosphamide use: two distinct patterns. Am J Respir Crit Care Med. 1996;154:1851-1856.
62. Alvarado CS, Boat TF, Newman AJ. Late-onset pulmonary fibrosis and chest deformity in two children with cyclophosphamide. J Pediatr. 1978;92:443-446.
63. O'Driscoll BR, Hasleton PS, Taylor PM, Poulter LW, Gattamaneni HR, Woodcock AA. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med. 1990;323:378-382.
64. Aronin PA, Mahaley MS, Rudnick SA, et al. Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors. N Engl J Med. 1980;303:183-188.
65. Dai MS, Ho CL, Chen YC, Kao WY, Chao TY. Acute respiratory distress syndrome following intrathecal methotrexate administration: a case report and review of the literature. Ann Hematol. 2000;79:696-699.
66. Wohl MEB, Griscom N, Tragis DG, Jaffe N. Effects of therapeutic irradiation delivered in early childhood upon subsequent lung function. Pediatrics. 1975;55:507-516.
67. Benoist MR, Lemerle J, Jean R, Rufin R, Scheinmann P, Paupe J. Effects of pulmonary function of whole lung irradiation for Wilm's tumour in children. Thorax. 1982;37:175-180.
68. Delanian S, Balla-Mekias S, Lefaix J. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol. 1999;17:3283-3290.
69. Molteni A, Moulder JE, Cohen EF, et al. Control of radiation induced pneumopathy and lung fibrosis by angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blocker. Int J Radiat Biol Phys. 2000;76:523-532.
70. Ettinger NE, Trulock EP. Pulmonary considerations of organ transplantation, Part 2. Am Rev Respir Dis. 1991;144:213-223.
71. Krowka MJ, Rosenow EC, Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest. 1985;87:237-246.
72. Worthy SA, Flint JD, Muller NL. Pulmonary complications after bone marrow transplantation: high resolution CT and pathologic findings. Radiographics. 1997;17:1359-1371.
73. Khurshid I, Anderson LC. Non-infectious complications after bone marrow transplantation. Postgrad Med J. 2002;78:257-262.
74. Ceveri I, Zoia MC, Fulgoni P, et al. Late pulmonary sequelae after childhood bone marrow transplantation. Thorax. 1999;54:131-135.
75. Kaplan EB, Wodell RA, Wilmott RW, Leifer B, Lesser ML. Late effects of bone marrow transplantation on pulmonary function in children. Bone Marrow Transplant. 1994;14:613-621.
76. Arvidson J, Bratteby LE, Carlson K, et al. Pulmonary function after autologous bone marrow transplantation in children. Bone Marrow Transplant. 1994;14:117-123.
77. Nysom K, Holm K, Hesse B, et al. Lung function after allogeneic bone marrow transplantation for leukaemia or lymphoma. Arch Dis Child. 1996;74:432-436.
78. Fanfulla F, Locatelli F, Zoia MC, et al. Pulmonary complications and respiratory function changes after bone marrow transplantation in children. Eur Respir J. 1997;10:2301-2306.
79. Keane TJ, Van Dyk J, Rider WD. Idiopathic interstitial pneumonia following bone marrow transplantation: the relationship with total body radiation. Int J Radiat Oncol Biol Phys. 1981;7:1365-1370.
80. Garaventa A, Rondelli R, Castagnola E, et al. Fatal pneumopathy in children after bone marrow transplantation: report from the Italian Registry. Italian Association of Pediatric Hematology-Oncology BMT Group. Bone Marrow Transplant. 1995;16:669-774.
81. Weiner RS, Bortin MM, Gale RP, Gluckman E, Kay HE, Kolb HJ. Interstitial pneumonitis after bone marrow transplantation: assessment of risk factors. Ann Intern Med. 1986;104:168-175.
82. Afessa B, Tefferi A, Litzow MR, Krowka MJ, Wylam ME, Peters SG. Diffuse alveolar hemorrhage in hematopoietic stem cell recipients. Am J Respir Care Med. 2002;166:641-645.
83. Sullivan KM, Dykewicz CA, Longworth DL, et al. Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation practice guidelines and beyond. Hematology. 2001;392-421.
84. Saavedra S, Jarque I, Sanz GF, et al. Infectious complications in patients undergoing unrelated donor bone marrow transplantation: experience from a single institution. Clin Microbiol Infect 2002;8:725-733.
85. Rolston KVI. The spectrum of pulmonary infections in cancer patients. Curr Opin Oncol. 2001;13:218-223.
86. Reichenberger F, Habicht J, Kaim A, et al. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases. Am J Respir Crit Care Med. 1998;158:885-890.
87. Graubner UB. Antiviral prophylaxis. Klin Padiatr. 2001;213:A69-A76.
88. Lones MA, Kirov I, Said JW, Shintaku IP, Neudorf S. Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient. Bone Marrow Transplant. 2000;26:1021-1024.
89. Collins J, Muller NL, Leung AN, et al. Epstein-Barr-virus-associated lymphoproliferative disease of the lung: CT and histologic findings. Radiology. 1998;208:749-759.
90. Kuehnle I, Huls MH, Liu Z, et al. CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hematopoietic stem cell transplantation. Blood. 2000;95:1502.
91. Goldmann A. ABC of palliative care: special problems in children. BMJ. 1998;316:49-52.
92. Hynson JL, Sawyer SM. Paediatric palliative care: Distinctive needs and emerging issues. J Paediatr Child Health. 2001;37:323-325.
93. Hongo T, Watanabe C, Okada S, et al. Analysis of the circumstances at the end of life in children with cancer: Symptoms, suffering and acceptance. Pediatrics Int 2003;45:60-64.
94. Hain RD, Patel N, Crabtree S, Pinkerton R. Respiratory symptoms in children dying from malignant disease. Palliat Med. 1995;9:201-206.
95. Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer. 2000;8:175-179.